Press Releases

All Releases
View Summary Intellipharmaceutics Announces Third Quarter 2010 Results
Oct 15, 2010
PDF 23.1 KB Add to Briefcase
View Summary Intellipharmaceutics' Co-founders Selected for Science and Technology Award
Oct 5, 2010
PDF 13.6 KB Add to Briefcase
View Summary Intellipharmaceutics to Present at JMP Securities Healthcare Conference
Sep 23, 2010
PDF 13.3 KB Add to Briefcase
View Summary Intellipharmaceutics Announces Second Quarter 2010 Results
Jul 14, 2010
PDF 24.3 KB Add to Briefcase
View Summary Intellipharmaceutics Provides Update on Activities Related to Venlafaxine Hydrochloride Extended Release Capsules
Jul 2, 2010
PDF 13.8 KB Add to Briefcase
View Summary Intellipharmaceutics Files ANDA With the FDA for Generic Protonix(R)
Jun 14, 2010
PDF 13.5 KB Add to Briefcase
View Summary Intellipharmaceutics Announces Significant Advance in Its Abuse-Deterrent Oxycodone Program
May 20, 2010
PDF 16.0 KB Add to Briefcase
View Summary FDA Accepts for Filing Intellipharmaceutics' ANDA for Generic Effexor XR(R)
May 7, 2010
PDF 13.5 KB Add to Briefcase
View Summary Intellipharmaceutics Announces First Quarter 2010 Results
Apr 13, 2010
PDF 23.6 KB Add to Briefcase
View Summary Intellipharmaceutics Announces Settlement for its Generic Version of Focalin XR(R)
Mar 11, 2010
PDF 14.6 KB Add to Briefcase
View Summary Intellipharmaceutics Announces 2009 Eleven Month Period End Results
Mar 1, 2010
PDF 24.9 KB Add to Briefcase
View Summary Intellipharmaceutics to Host Conference Call and Webcast on March 1, 2010 at 10:00 a.m. Eastern Time
Feb 23, 2010
PDF 15.9 KB Add to Briefcase
View Summary Intellipharmaceutics Announces Appointment of Chief Financial Officer
Feb 12, 2010
PDF 14.7 KB Add to Briefcase
View Summary IntelliPharmaCeutics International Inc. Announces Third Quarter 2009 Results of IntelliPharmaCeutics Ltd.
Nov 12, 2009
PDF 67.0 KB Add to Briefcase
View Summary Intellipharmaceutics and Vasogen Inc. Complete Arrangement to Create Publicly-traded Specialty Pharmaceutical Company
Oct 22, 2009
PDF 15.1 KB Add to Briefcase
View Summary Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company
Aug 17, 2009
PDF 18.0 KB Add to Briefcase
View Summary IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone
Mar 27, 2008
PDF 14.3 KB Add to Briefcase
View Summary IntelliPharmaCeutics Ltd. Announces Generic Drug Commercialization Activities
Oct 22, 2007
PDF 11.4 KB Add to Briefcase
View Summary IntelliPharmaCeutics Announces Equity Investment by Par Pharmaceutical
Aug 1, 2007
PDF 11.3 KB Add to Briefcase
Showing 141-159 of 159 Page: 1 ... 6 7 8  Previous 20
=add release to Briefcase